Products

Characters AI Chat

AI-native

Your next conversation starts here

charactersaichat.com Entertainment & Media / AI Companions & Character Chat

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
chandima lahiru
No social account linked
Launched
26d ago
2026-10-20 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events2 marketing moves

Marketing moves

Launches, search & content, referrals, promotions

  • Launched on Product HuntLaunch

    Free AI character chat and interactive roleplay platform

    Nov 8 · 7d agoLaunch page

    At the time: <5K visits/mo1 concurrent move

  • Launched on Product HuntLaunch

    Create & Talk to AI Chatbots for Free

    Oct 20 · 26d agoLaunch page

    At the time: <5K visits/mo1 concurrent move

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority 0.4Domain registered 2026-08-28

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-10-20

Key pages

Weekly snapshots
charactersaichat.com/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Characters AI Chat get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Characters AI Chat and what platforms does it support?
Characters AI Chat is catalogued under AI Companions & Character Chat: Your next conversation starts here. Supported platforms: Web.

Related products in this category

Entertainment & Media / AI Companions & Character Chat

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.